MXPA04000042A - Formulacion medicinal inyectable para uso en un diagnostico o una terapia fotodinamica y metodo para preparar la misma. - Google Patents
Formulacion medicinal inyectable para uso en un diagnostico o una terapia fotodinamica y metodo para preparar la misma.Info
- Publication number
- MXPA04000042A MXPA04000042A MXPA04000042A MXPA04000042A MXPA04000042A MX PA04000042 A MXPA04000042 A MX PA04000042A MX PA04000042 A MXPA04000042 A MX PA04000042A MX PA04000042 A MXPA04000042 A MX PA04000042A MX PA04000042 A MXPA04000042 A MX PA04000042A
- Authority
- MX
- Mexico
- Prior art keywords
- diagnosis
- photodynamic therapy
- formulation
- preparing same
- galenic formulation
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 238000009472 formulation Methods 0.000 title abstract 4
- 238000003745 diagnosis Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 238000002428 photodynamic therapy Methods 0.000 title abstract 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract 3
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 abstract 2
- 239000003504 photosensitizing agent Substances 0.000 abstract 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N EtOH Substances CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- -1 alkali metal salt Chemical class 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 239000008346 aqueous phase Substances 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Virology (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La invencion se refiere a una formulacion medicinal inyectable para uso en un diagnostico o una terapia fotodinamica y el metodo de preparacion de la misma. La formulacion contiene: un compuesto de la formula general (I), en donde: R2 representa un H, OH o grupo COOR4, en donde R4 es un hidrogeno o un alquilo C1-C12 o un Cicloalquilo C3-C12; R3 representa un H, OH o un alquilo o alcoxi C1 - C12; y * representa un carbono asimetrico en la forma de una sal de metal alcalino en una cantidad que no excede de 10 mg/ml, como agente de fotosensibilizacion, y un portador en una fase acuosa que contiene por lo menos una mezcla de alcohol bencilico - etanol o propilenglicol como agente de solubilizacion para el agente de fotosensibilizacion y un agente tensioactivo en una cantidad que no excede 20% en peso con relacion al peso total de la formulacion.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01810708A EP1277470A1 (fr) | 2001-07-17 | 2001-07-17 | Formulation galénique injectable pour utilisation dans un diagnostic ou une thérapie photodynamique et son procédé de préparation |
| PCT/IB2002/002661 WO2003009842A1 (fr) | 2001-07-17 | 2002-07-05 | Formulation galenique injectable pour utilisation dan un diagnostic ou une therapie photodynamique et son procede de preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA04000042A true MXPA04000042A (es) | 2005-08-16 |
Family
ID=8184036
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA04000042A MXPA04000042A (es) | 2001-07-17 | 2002-07-05 | Formulacion medicinal inyectable para uso en un diagnostico o una terapia fotodinamica y metodo para preparar la misma. |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20040147500A1 (es) |
| EP (2) | EP1277470A1 (es) |
| JP (1) | JP2004537562A (es) |
| CN (1) | CN1303999C (es) |
| AT (1) | ATE372769T1 (es) |
| BR (1) | BR0211173A (es) |
| CA (1) | CA2454150A1 (es) |
| DE (1) | DE60222421T2 (es) |
| DK (1) | DK1406616T3 (es) |
| ES (1) | ES2292781T3 (es) |
| HU (1) | HUP0400754A3 (es) |
| IL (1) | IL159620A0 (es) |
| MX (1) | MXPA04000042A (es) |
| NO (1) | NO20040216L (es) |
| NZ (1) | NZ530634A (es) |
| PL (1) | PL368503A1 (es) |
| PT (1) | PT1406616E (es) |
| RU (1) | RU2278665C2 (es) |
| WO (1) | WO2003009842A1 (es) |
| ZA (1) | ZA200400328B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7825153B2 (en) * | 2004-08-16 | 2010-11-02 | Ceramoptec Industries, Inc. | Photosensitizer formulations and their use |
| KR100866728B1 (ko) * | 2004-11-12 | 2008-11-03 | 주식회사종근당 | 타크로리무스를 함유하는 주사제 |
| EP2008665A1 (fr) * | 2007-06-25 | 2008-12-31 | Steba Biotech N.V. | Formulation injectable pour thérapie photodynamique |
| RU2565766C1 (ru) * | 2014-11-17 | 2015-10-20 | Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии и регенеративной медицины имени Е.Л. Гольдберга" | 4-(3,4-дибромтиофенкарбонил)-2,6,8,12-тетраацетил-2,4,6,8,10,12-гексаазатетрацикло[5,5,0,03,11,05,9]додекан в качестве анальгетического средства и способ его получения |
| ES2895851T3 (es) * | 2016-04-01 | 2022-02-22 | Trioptotec Gmbh | Dispersión de fotosensibilizador y uso de la misma |
| CN108670950B (zh) * | 2018-06-29 | 2020-10-02 | 深圳海王医药科技研究院有限公司 | 一种不含有机溶剂的虎杖苷药物组合物及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2963178B2 (ja) * | 1990-09-27 | 1999-10-12 | 株式会社エス・エル・ティ・ジャパン | 水溶性フェオホーバイドａの製造方法 |
| US5654423A (en) * | 1990-11-21 | 1997-08-05 | Regents Of The University Of California | Boronated metalloporphyrine and therapeutic methods |
| AU5959994A (en) * | 1992-12-23 | 1994-07-19 | Iowa State University Research Foundation Inc. | Molecular flashlight |
| US6147195A (en) * | 1993-07-26 | 2000-11-14 | Yeda Research And Development Co., Ltd. | Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them |
| US5462726A (en) * | 1993-12-17 | 1995-10-31 | Bristol-Myers Squibb Company | Method of inhibiting side effects of solvents containing ricinoleic acid or castor oil or derivatives thereof employing a thromboxane A2 receptor antagonist and pharmaceutical compositions containing such solvents |
| US5616342A (en) * | 1995-04-11 | 1997-04-01 | Pdt, Inc. | Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof |
| IL116126A0 (en) * | 1995-11-24 | 1996-01-31 | Yeda Res & Dev | Process for the preparation of bacteriochlorophyllis some novel compounds of this type and pharmaceutical compositions comprising them |
| RU2144085C1 (ru) * | 1996-07-12 | 2000-01-10 | Московская государственная академия тонкой химической технологии им.М.В.Ломоносова | Способ получения бактериохлорофилла а |
| NZ512093A (en) * | 1998-12-09 | 2003-04-29 | Yeda Res & Dev | Palladium-substituted bacteriochlorophyll derivatives and use thereof |
-
2001
- 2001-07-17 EP EP01810708A patent/EP1277470A1/fr not_active Withdrawn
-
2002
- 2002-07-05 PL PL02368503A patent/PL368503A1/xx unknown
- 2002-07-05 PT PT02747627T patent/PT1406616E/pt unknown
- 2002-07-05 US US10/484,154 patent/US20040147500A1/en not_active Abandoned
- 2002-07-05 ES ES02747627T patent/ES2292781T3/es not_active Expired - Lifetime
- 2002-07-05 MX MXPA04000042A patent/MXPA04000042A/es active IP Right Grant
- 2002-07-05 IL IL15962002A patent/IL159620A0/xx unknown
- 2002-07-05 BR BR0211173-0A patent/BR0211173A/pt not_active IP Right Cessation
- 2002-07-05 NZ NZ530634A patent/NZ530634A/en unknown
- 2002-07-05 WO PCT/IB2002/002661 patent/WO2003009842A1/fr not_active Ceased
- 2002-07-05 RU RU2004104469/15A patent/RU2278665C2/ru not_active IP Right Cessation
- 2002-07-05 EP EP02747627A patent/EP1406616B1/fr not_active Expired - Lifetime
- 2002-07-05 CA CA002454150A patent/CA2454150A1/fr not_active Abandoned
- 2002-07-05 AT AT02747627T patent/ATE372769T1/de not_active IP Right Cessation
- 2002-07-05 DE DE60222421T patent/DE60222421T2/de not_active Expired - Fee Related
- 2002-07-05 CN CNB028142918A patent/CN1303999C/zh not_active Expired - Fee Related
- 2002-07-05 HU HU0400754A patent/HUP0400754A3/hu unknown
- 2002-07-05 DK DK02747627T patent/DK1406616T3/da active
- 2002-07-05 JP JP2003515235A patent/JP2004537562A/ja active Pending
-
2004
- 2004-01-15 ZA ZA200400328A patent/ZA200400328B/en unknown
- 2004-01-16 NO NO20040216A patent/NO20040216L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2454150A1 (fr) | 2003-02-06 |
| CN1303999C (zh) | 2007-03-14 |
| HUP0400754A3 (en) | 2005-11-28 |
| ES2292781T3 (es) | 2008-03-16 |
| DE60222421D1 (de) | 2007-10-25 |
| EP1277470A1 (fr) | 2003-01-22 |
| US20040147500A1 (en) | 2004-07-29 |
| EP1406616A1 (fr) | 2004-04-14 |
| ZA200400328B (en) | 2004-09-13 |
| WO2003009842A1 (fr) | 2003-02-06 |
| DE60222421T2 (de) | 2008-06-05 |
| IL159620A0 (en) | 2004-06-01 |
| ATE372769T1 (de) | 2007-09-15 |
| PL368503A1 (en) | 2005-04-04 |
| JP2004537562A (ja) | 2004-12-16 |
| NO20040216L (no) | 2004-03-17 |
| HUP0400754A2 (hu) | 2004-07-28 |
| WO2003009842A8 (fr) | 2004-04-01 |
| EP1406616B1 (fr) | 2007-09-12 |
| RU2004104469A (ru) | 2005-04-20 |
| CN1529594A (zh) | 2004-09-15 |
| BR0211173A (pt) | 2004-08-10 |
| RU2278665C2 (ru) | 2006-06-27 |
| PT1406616E (pt) | 2007-12-20 |
| NZ530634A (en) | 2006-11-30 |
| DK1406616T3 (da) | 2008-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2113229A1 (en) | Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof | |
| NZ332363A (en) | substituted 4-hydroxy-isoquinoline-3carboxamide derivatives and medicaments | |
| EP1340755A4 (en) | AGENT WITH EFFECT AGAINST HELICOBACTER | |
| MY118904A (en) | 4-oxo-1, 4-dihydro-3-quinolinecarboxamides as antiviral agents | |
| NZ527522A (en) | Use of a chemopreventative agent in a method for chemoprevention of prostate cancer | |
| NZ329649A (en) | Carbapenem antibiotics and preparation thereof | |
| HU9202047D0 (en) | Method for producing n-phenyl-thiourea derivatives and pharmaceutical prepartives containing these compounds as active agents | |
| MXPA04000042A (es) | Formulacion medicinal inyectable para uso en un diagnostico o una terapia fotodinamica y metodo para preparar la misma. | |
| ATE156119T1 (de) | 2-formylpyridin-thiosemicarbazonderivate, ihre herstellung und ihre verwendung als antitumor mittel | |
| KR950703941A (ko) | 일산화질소 합성 억제제(nitrogen monoxide synthesis inhibitor) | |
| KR950703341A (ko) | 항부정맥제 | |
| GB9125970D0 (en) | New compounds | |
| WO2000063215A3 (fr) | Derives d'indazole, leur preparation et leur application en therapeutique | |
| DE69812028D1 (de) | Creatine Derivate für Asthma | |
| EP1325748A4 (en) | PROPHYLACTIC OR THERAPEUTIC DRUGS AGAINST CANCER CONTAINING CYANIDINE COMPOUNDS AS AN ACTIVE AGENT | |
| EP1156057A4 (en) | MALTO-OLIGOSACCHARID DERIVATIVES AND THEIR APPLICATIONS | |
| EP0860169A3 (en) | Compositions for oral administration containing pyridazinone compounds | |
| MXPA05014127A (es) | Uso de derivados de biciclo[2.2.1]heptano para la preparacion de composiciones farmaceuticas neuroprotectoras. | |
| GB2358398B (en) | Steroid compounds, a method for preparation thereof, pharmaceutical compositions containing the same and use thereof | |
| NO983217L (no) | Terapeutiske anti-astmamidler som inneholder selenforbindeler | |
| CA2015049A1 (en) | Pharmaceutically efficacious pteridine derivatives | |
| EA200100357A1 (ru) | Способ стабилизации водного раствора производного пиразолоакридона | |
| MXPA06000651A (es) | Uso de derivados de indazol para el tratamiento de dolor neuropatico. | |
| ATE298329T1 (de) | Aminoflavonverbindungen, zusammensetzungen und ihre verwendung | |
| DE60203029D1 (de) | Benzopyran Derivate und diese enthaltende Antiallergisches Mittel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |